|
Biblio |
Nom latin :nicotiana tabacum Nom français :tabac Nom anglais :tobacco |
|
Source
: Liberty Science Center |
Le tabac est une plante rudérale*, annuelle, qui
présente des tiges herbacées. Selon les espèces, la plante peut mesurer plus de deux
mètres (Nicotiana tabacum) à moins d'un mètre (Nicotiana rustica). *Rudérale
: se dit d'une plante qui croît dans les ruines, parmi les décombres. Source : http://r0.unctad.org |
|
Localisation Origine |
Le tabac est originaire des Amériques où il était connu
des civilisations précolombiennes il y a déjà plus de 2000 ans. Source : http://r0.unctad.org |
|
Propriétés, composition |
Le tabac doit principalement à un alcaloïde, la
nicotine, ses qualités organoleptiques; on la trouve dans toutes les parties
de la plante. La teneur varie de 1 à 10 % suivant les espèces et variétés. La
nicotine est très toxique. Elle est associée à un autre principe actif, la
nicotianine, qui paraît communiquer au tabac son arôme spécifique Source : http://www.congonline.com
Source : http://www.planete.org/herbier/grd_tab.html Régule
l'énergie, purgative, migraine, dégoût. Pour la protection et apprendre
comment guérir. Donne le savoir. Source : http://www.ayahuasca-wasi.com/frances/libro/sistema_curanderil.htm |
|
Avertissement |
Toxicité : Source : http://www.planete.org |
|
De même famille |
Famille : solanaceae Genre :nicotiana Autre espèce : Nicotiana rustica |
|
Références |
[1-50] |
1. Baltussen, R., Priority setting of public spending in developing countries: Do not try
to do everything for everybody. Health Policy, 2005.
2. Kang, T.J., et al., Expression of synthetic neutralizing epitope of porcine epidemic
diarrhea virus fused with synthetic B subunit of Escherichia coli heat-labile
enterotoxin in tobacco plants. Protein Expr Purif, 2005.
3. Kang, T.J., et al., Cloning and sequence analysis of the Korean strain of spike gene of
porcine epidemic diarrhea virus and expression of its neutralizing epitope in
plants. Protein Expr Purif, 2005. 41(2):
p. 378-83.
4. Kang, T.J., et al., Expression of the synthetic neutralizing epitope gene of porcine
epidemic diarrhea virus in tobacco plants without nicotine. Vaccine, 2005. 23(17-18): p. 2294-7.
5. Kang, T.J., et al., High-level expression of the neutralizing epitope of porcine epidemic
diarrhea virus by a tobacco mosaic virus-based vector. Protein Expr Purif,
2004. 38(1): p. 129-35.
6. Joensuu, J.J., et al., Fimbrial subunit protein FaeG expressed in
transgenic tobacco inhibits the binding of F4ac enterotoxigenic Escherichia
coli to porcine enterocytes. Transgenic
Res, 2004. 13(3): p. 295-8.
7. Losman,
J.A. and K. Cavanaugh, Cases from the
Osler Medical Service at Johns Hopkins University. Diagnosis: P. carinii
pneumonia and primary pulmonary sporotrichosis. Am J Med, 2004. 117(5): p. 353-6.
8. Delgado-Aros,
S., et al., Obesity is associated with
increased risk of gastrointestinal symptoms: a population-based study. Am J
Gastroenterol, 2004. 99(9): p.
1801-6.
9. Judge,
N.A., H.S. Mason, and A.D. O'Brien, Plant
cell-based intimin vaccine given orally to mice primed with intimin reduces
time of Escherichia coli O157:H7 shedding in feces. Infect Immun, 2004. 72(1): p. 168-75.
10. Bae,
J.L., et al., Induction of
antigen-specific systemic and mucosal immune responses by feeding animals
transgenic plants expressing the antigen. Vaccine, 2003. 21(25-26): p. 4052-8.
11. Hunt,
C.E., et al., Infant sleep position and
associated health outcomes. Arch Pediatr Adolesc Med, 2003. 157(5): p. 469-74.
12. Nichols,
L., D.C. Strollo, and S. Kusne, Legionellosis
in a lung transplant recipient obscured by cytomegalovirus infection and
Clostridium difficile colitis. Transpl Infect Dis, 2002. 4(1): p. 41-5.
13. Comolet,
T.M., R. Rakotomalala, and C.A. Tsimaniry, [Do
health workers practice what they preach? A study of knowledge, opinions and
practices of health care professionals, with respect to their own health, in
Madagascar]. Sante, 2000. 10(1):
p. 5-10.
14. McBride,
J.S., et al., Green tobacco sickness.
Tob Control, 1998. 7(3): p. 294-8.
15. Friis,
L., L. Agreus, and C. Edling, Abdominal
symptoms among sewage workers. Occup Med (Lond), 1998. 48(4): p. 251-3.
16. Baker,
D., H. Taylor, and J. Henderson, Inequality
in infant morbidity: causes and consequences in England in the 1990s. ALSPAC
Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J Epidemiol
Community Health, 1998. 52(7): p.
451-8.
17. Gatti,
G., et al., Population pharmacokinetics
of rifabutin in human immunodeficiency virus-infected patients. Antimicrob
Agents Chemother, 1998. 42(8): p.
2017-23.
18. Evans,
C.A., et al., Gastric acid secretion and
enteric infection in Bangladesh. Trans R Soc Trop Med Hyg, 1997. 91(6): p. 681-5.
19. Hannerz,
J., Symptoms and diseases and smoking
habits in female episodic cluster headache and migraine patients.
Cephalalgia, 1997. 17(4): p.
499-500.
20. Moawad,
J., et al., Current results of surgical
therapy for chronic mesenteric ischemia. Arch Surg, 1997. 132(6): p. 613-8; discussion 618-9.
21. Murray,
C.J. and A.D. Lopez, Global mortality,
disability, and the contribution of risk factors: Global Burden of Disease
Study. Lancet, 1997. 349(9063):
p. 1436-42.
22. Farrow,
A., et al., Nitrogen dioxide, the oxides
of nitrogen, and infants' health symptoms. ALSPAC Study Team. Avon Longitudinal
Study of Pregnancy and Childhood. Arch Environ Health, 1997. 52(3): p. 189-94.
23. Dhawan,
P.S. and H.G. Desai, Prevention of
gastrointestinal diseases. Natl Med J India, 1996. 9(2): p. 72-5.
24. McCarthy,
P.L., et al., Fever without apparent
source on clinical examination, lower respiratory infections in children,
bacterial infections, and acute gastroenteritis and diarrhea of infancy and
early childhood. Curr Opin Pediatr, 1995. 7(1): p. 107-25.
25. Sigsgaard,
T., et al., Respiratory disorders and
atopy in Danish refuse workers. Am J Respir Crit Care Med, 1994. 149(6): p. 1407-12.
26. Halken,
S., et al., [Prevention of allergy in
infants. A prospective study of 159 high-risk children]. Ugeskr Laeger, 1994. 156(3):
p. 308-12.
27. Halken,
S., et al., Effect of an allergy
prevention programme on incidence of atopic symptoms in infancy. A prospective
study of 159 "high-risk" infants. Allergy, 1992. 47(5): p. 545-53.
28. Brock,
K.V., R. Deng, and S.M. Riblet, Nucleotide
sequencing of 5' and 3' termini of bovine viral diarrhea virus by RNA ligation
and PCR. J Virol Methods, 1992. 38(1):
p. 39-46.
29. Vella,
V., et al., Determinants of child
nutrition and mortality in north-west Uganda. Bull World Health Organ,
1992. 70(5): p. 637-43.
30. Ponka,
A., et al., Infections and other
illnesses of children in day-care centers in Helsinki. I: Incidences and
effects of home and day-care center variables. Infection, 1991. 19(4): p. 230-6.
31. Vig,
M.M., Nicotine poisoning in a dog.
Vet Hum Toxicol, 1990. 32(6): p.
573-5.
32. Black,
R.E., Prevention in developing countries.
J Gen Intern Med, 1990. 5(5 Suppl): p. S132-5.
33. Neertoft,
S., [Children's conditions. Peace should
be used for the children's advantage]. Sygeplejersken, 1990. 90(9): p. 10-1, 27.
34. Seitz,
J.F., et al., [Endoscopic detection of
dysplasia and subclinical cancer of the esophagus. Results of a prospective
study using toluidine blue vital staining in 100 patients with alcoholism and
smoking]. Gastroenterol Clin Biol, 1990.
14(1): p.
15-21.
35. Burr,
M.L., et al., Environmental factors and
symptoms in infants at high risk of allergy. J Epidemiol Community Health,
1989. 43(2): p. 125-32.
36. Walsh,
J.A., Disease problems in the Third
World. Ann N Y Acad Sci, 1989. 569:
p. 1-16.
37. Goldin,
E., et al., Comparison of misoprostol and
ranitidine in the treatment of duodenal ulcer. Isr J Med Sci, 1988. 24(6): p. 282-5.
38. Ashworth,
A. and R.G. Feachem, Interventions for
the control of diarrhoeal diseases among young children: prevention of low
birth weight. Bull World Health Organ, 1985. 63(1): p. 165-84.
39. Fischer,
A.B., N. Graem, and L.A. Christiansen, Causes
and clinical significance of gastritis following Billroth II resection for
duodenal ulcer. Br J Surg, 1983. 70(6): p. 322-5.
40. Keys,
T.F., Legionnaires' disease: a review of
the epidemiology and clinical manifestations of a newly recognized infection.
Mayo Clin Proc, 1980. 55(3): p.
129-37.
41. Huy, N.D.
and P.E. Roy, Inhalation of tobacco and
marijuana in dog over a period of 30 months: effect on body weight, food intake
and organ weight. Res Commun Chem Pathol Pharmacol, 1976. 13(3): p. 465-72.
42. Huy,
N.D., R. Belleau, and P.E. Roy, Toxicity
of marijuana and tobacco smoking in the beagle. Int J Clin Pharmacol
Biopharm, 1975. 12(1-2): p. 267-76.
43. Bele, B.
and E. Mohobo, [A case of acute tobacco
poisoning by enema]. Ann
Anesthesiol Fr, 1975. 16(2): p.
97-100.
44. Hajek,
P., F. Gillison, and H. McRobbie, Stopping
smoking can cause constipation. Addiction,
2003. 98(11): p. 1563-7.
45. Kravetz,
R.E., Tobacco enema. Am J
Gastroenterol, 2002. 97(9): p.
2453.
46. Rose,
J.E., et al., Platelet monoamine oxidase,
smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res, 2001.
3(4): p. 383-90.
47. Lancaster,
T. and L.F. Stead, Mecamylamine (a
nicotine antagonist) for smoking cessation. Cochrane Database Syst Rev,
2000(2): p. CD001009.
48. Charlett,
A., et al., Cortisol is higher in
parkinsonism and associated with gait deficit. Acta Neurol Scand, 1998. 97(2): p. 77-85.
49. Christiansen,
J., ["Surveys of possible positive
effect of tobacco on intestinal function". A historically based
meta-analysis]. Ugeskr Laeger, 1997. 159(51): p. 7669-72.
50. Cummings,
K.M., et al., Reports of smoking
withdrawal symptoms over a 21 day period of abstinence. Addict Behav, 1985.
10(4): p. 373-81.